UK markets closed
NIKKEI 225
27,120.53 +128.32 (+0.48%) HANG SENG
18,087.97 +1,008.46 (+5.90%) CRUDE OIL
87.37 +0.85 (+0.98%) GOLD FUTURES
1,719.60 -10.90 (-0.63%) DOW
30,120.50 -195.82 (-0.65%) BTC-GBP
17,775.78 -56.00 (-0.31%)
Merck & Co., Inc. (MRK)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 12:41PM EDT. Market open.
| Previous close | 88.39 |
| Open | 88.58 |
| Bid | 88.54 x 900 |
| Ask | 88.55 x 1100 |
| Day's range | 88.03 - 88.78 |
| 52-week range | 71.50 - 95.72 |
| Volume | |
| Avg. volume | 8,155,028 |
| Market cap | 224.322B |
| Beta (5Y monthly) | 0.34 |
| PE ratio (TTM) | 13.52 |
| EPS (TTM) | 6.55 |
| Earnings date | 27 Oct 2022 |
| Forward dividend & yield | 2.76 (3.12%) |
| Ex-dividend date | 14 Sept 2022 |
| 1y target est | 100.90 |
- Zacks
Is Exelixis' (EXEL) Growth Story Likely to Continue?
Exelixis' (EXEL) efforts to expand Cabometyx's label and develop additional drugs to expand its portfolio should reap rewards for the company.
- Zacks
Iovance (IOVA) Focuses on Seeking Nod for Melanoma Therapy
Iovance (IOVA) is progressing with its pipeline development. Management, after many delays, initiated a rolling BLA filing with the FDA for its lead candidate in metastatic melanoma.
- Zacks
Merck (MRK) Gains But Lags Market: What You Should Know
Merck (MRK) closed at $87.55 in the latest trading session, marking a +1.66% move from the prior day.
© 2022 Yahoo. All rights reserved.
